AKT1 and COVID-19: PI3K/Akt signaling specifically is over-activated in COVID-19 patients and could affect SARS-CoV-2 entry and replication in the host cells by regulating the clathrin-mediated endocytosis and glycolysis (Khezri et al., 2022).